Ciclonicate

This classification denotes an antilipolytic and a myolytic and nicotinic acid with the molecular formula C15H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7H634NXI03, chemically known as 3-pyridinecarboxylic acid, 3,3,5-trimethylcyclohexyl ester, trans- but generally known as ciclonicate, which bears US NIH Compound Identifier 68703. European Medicines Agency schedules Ciclonicate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06243MIG. World Health Organization schedules ciclonicate in its Anatomical Therapeutic Chemical (ATC) Classification. CICLONICATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Ciclonicate under HS 29333999 and SITC 51574. As of Q4 2014, CICLONICATE remains the US FDA Preferred Term for this commodity. SMILES: C[C@@H]1C[C@H](CC(C1)(C)C)OC(=O)C2CCCNC2.